The end of the Prozac era: why pharma is abandoning psychiatry
A short history of psychiatry in the West The 1950s was a revolutionary era for the clinical introduction of new
Read moreBlog
From bench to bedside: Difficulties in spinal cord injury clinical trials
In developing new treatments for any disease or disorder, translating lab results to clinical benefits is a major challenge. The
Read moreAgeing as a therapeutic target
Ageing is one of the biggest causes of human suffering. It results in a functional decline in almost every organ
Read moreHow to fix a spinal cord injury
Spinal cord injuries have the potential to be devastating and life-changing events. After an injury has taken place, clinicians decide
Read moreYour weekly BMJ digest – 20/5/17
It’s been a difficult week here in the UK and with the fast pace of current events, it seems the
Read moreYour weekly BMJ digest – 13/5/17
We’re feeling ripples from the tumultuous outside world in this week’s BMJ. From the rare/raw steak on its cover, which
Read moreNeurodegenerative disease and its burden on society
The UK has an ageing population and with longer life expectancies more of us will suffer from neurodegenerative diseases. These
Read moreYour weekly BMJ digest – 06/5/17
Another week, another BMJ, but there is one thing you can rely on. During my many painful hours reading the
Read moreYour weekly BMJ digest – 29/4/17
So to do these summaries I go to my hospital library and use their copy of the BMJ (there’s less
Read moreThe road to research in non-traumatic spinal cord injury
Think of the spinal cord as a busy motorway, and cars as the electrical signals travelling from distant sites to
Read more
